Venmax Drugs & Pharmaceuticals Ltd (531015) — Board Meeting | 31 August 2026
Venmax Drugs & Pharmaceuticals announced board approval of the 2025-26 Directors Report, Secretarial Audit, and 37th AGM scheduled for September 26, 2026 via video conference, with e-voting from September 23-25 and shareholder record dates set for September 18-26, 2026.
About Venmax Drugs & Pharmaceuticals Ltd (531015)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 531015 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 531015 — Free💡 Ask AI about this filing
📊 More 531015 filings
- 🔴 Annual Report — 1 September 2026 Venmax Drugs & Pharmaceuticals Limited submitted its 2025-26 Annual Report to BSE on September 1, 20...
🔥 Also filed on 31 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd